The Challenge of Nanovesicles for Selective Topical Delivery for Acne Treatment: Enhancing Absorption Whilst Avoiding Toxicity

References

• Purdy S, de Berker D. Acne vulgaris. BMJ Clin Evid. 2011;2011:1714.
   PubMedGoogle Scholar
• Kim J-Y, Lee W-R, Kim K-H, et al. Effects of bee venom against propionibacterium acnes-induced inflammation in human keratinocytes and monocytes. Int J Mol Med. 2015;35:1651–1656. doi:10.3892/ijmm.2015.218025872535
   PubMed Web of Science ®Google Scholar
• Dréno B, Bettoli V, Araviiskaia E, Viera MS, Bouloc A. The influence of exposome on acne. JEADV. 2018;32(5):812–819.29377341
   PubMedGoogle Scholar
• Salman A, Kurt E, Topcuoglu V, Demircay Z. Social anxiety and quality of life in vitiligo and acne patients with facial involvement: a Cross-Sectional Controlled Study. Am J Clin Dermatol. 2016;17(3):305–311. doi:10.1007/s40257-016-0172-x26818062
   PubMed Web of Science ®Google Scholar
• Samuels DV, Rosenthal R, Lin R, Chaudhari S, Natsuaki MN. Acne vulgaris and risk of depression and anxiety: a meta-analytic review. J Am Acad Dermatol. 2020;83(2):P532–P541. doi:10.1016/j.jaad.2020.02.040
   PubMed Web of Science ®Google Scholar
• Tripathi SV, Gustafson CJ, Huang KE, Feldman SR. Side effects of common acne treatment. Expert Opin Drug Saf. 2013;12(1):39–51. doi:10.1517/14740338.2013.74045623163336
   PubMed Web of Science ®Google Scholar
• Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973.e33. doi:10.1016/j.jaad.2015.12.03726897386
   PubMed Web of Science ®Google Scholar
• Gollnick H. Current concepts of the pathogenesis of acne implications for drug treatment. Drugs. 2003;63(15):1579–1596. doi:10.2165/00003495-200363150-0000512887264
   PubMed Web of Science ®Google Scholar
• Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol. 2003;4(7):473–492. doi:10.2165/00128071-200304070-0000412814337
   PubMed Web of Science ®Google Scholar
• Krautheim A, Gollnick HPM. Acne: topical treatment. Clin Dermatol. 2004;22(5):398–407. doi:10.1016/j.clindermatol.2004.03.00915556726
   PubMed Web of Science ®Google Scholar
• Otlewska A, Baran W, Batycka-Baran A. Adverse events related to topical drug treatments for acne vulgaris. Expert Opin Drug Saf. 2020;19(4):513–521. doi:10.1080/14740338.2020.175764632347138
   PubMed Web of Science ®Google Scholar
• Valacchi G, Rimbach G, Saliou C, Weber SU, Packer L. Effect of benzoyl peroxide on antioxidant status, NF-kB activity and interleukin-1α gene expression in human keratinocytes. Toxicology. 2001;165(2–3):225–234. doi:10.1016/S0300-483X(01)00430-911522381
   PubMed Web of Science ®Google Scholar
• Worret WI, Fluhr JW. Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid. JDDG. 2006;4(4):293–300. doi:10.1111/j.1610-0387.2006.05931.x16638058
   PubMedGoogle Scholar
• Sagransky M, Yentzer BA, Feldman SR. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Expert Opin Pharmacother. 2009;10(15):2555–2562.19761357
   PubMed Web of Science ®Google Scholar
• Schulte BC, Wu W, Rosen T. Azelaic acid: evidence-based update on mechanism of action and clinical application. J Drugs Dermatol. 2015;14(9):964–968.26355614
   PubMed Web of Science ®Google Scholar
• Hamilton FL, Car J, Lyons C, Car M, Layton A, Majeed A. Laser and other light therapies for the treatment of acne vulgaris: systematic review. Br J Dermatol. 2009;160(6):1273–1285. doi:10.1111/j.1365-2133.2009.09047.x19239470
   PubMed Web of Science ®Google Scholar
• Gorzelanny C, Mess C, Schneider SW, Huck V, Brandner JM. Skin barriers in dermal drug delivery: which barriers have to be overcome and how can we measure them? Pharmaceutics. 2020;12(7):684. doi:10.3390/pharmaceutics12070684
   PubMed Web of Science ®Google Scholar
• Vasanth S, Dubey A, Ravi GS, et al. Development and investigation of vitamin C-enriched adapalene-loaded transfersome gel: a collegial approach for the treatment of acne vulgaris. AAPS PharmSciTech. 2020;21(2):61. doi:10.1208/s12249-019-1518-531915948
   PubMed Web of Science ®Google Scholar
• Molinaro R, Gagliardi A, Mancuso A, et al. Development and in vivo evaluation of multidrug ultradeformable vesicles for the treatment of skin inflammation. pharmaceutics. Pharmaceutics. 2019;11(12):644. doi:10.3390/pharmaceutics11120644
   PubMed Web of Science ®Google Scholar
• Liu Q, Das M, Liu Y, Huang L. Targeted drug delivery to melanoma. Adv Drug Deliv Rev. 2018;127:208–211. doi:10.1016/j.addr.2017.09.01628939379
   PubMed Web of Science ®Google Scholar
• Latter G, Grice JE, Mohammed Y, Roberts MS, Benson HAE. Targeted topical delivery of retinoids in the management of acne vulgaris: current formulations and novel delivery systems. Pharmaceutics. 2019;11(10):490. doi:10.3390/pharmaceutics11100490
   PubMed Web of Science ®Google Scholar
• Cristiano MC, Froiio F, Mancuso A, et al. In vitro and in vivo trans-epidermal water loss evaluation following topical drug delivery systems application for pharmaceutical analysis. J Pharm Biomed. 2020;186:113295. doi:10.1016/j.jpba.2020.113295
   PubMed Web of Science ®Google Scholar
• Schmid M-H, Korting HC. Therapeutic progress with topical liposome drugs for skin disease. Adv Drug Deliv Rev. 1996;18(3):335–342. doi:10.1016/0169-409X(95)00019-4
   Web of Science ®Google Scholar
• Honzak L, Sentjurc M. Development of liposome encapsulated clindamycin for treatment of acne vulgaris. Pflugers Arch. 2000;445(Suppl5):R44–R45.
   Google Scholar
• Patel VB, Misra A, Marfatia YS. Topical liposomal gel of tretinoin for the treatment of acne: research and clinical implications. Pharm Dev Technol. 2000;5:455–464. doi:10.1081/PDT-10010202911109245
   PubMed Web of Science ®Google Scholar
• Schäfer-Korting M, Korting HC, Ponce-Pöschl E. Liposomal tretinoin for uncomplicated acne vulgaris. Clin Investig. 1994;72:1086–1091. doi:10.1007/BF00577761
   PubMedGoogle Scholar
• Lasic DD. Novel applications of liposomes. Trends Biotechnol. 1998;16(7):307–321. doi:10.1016/S0167-7799(98)01220-79675915
   PubMed Web of Science ®Google Scholar
• Skalko N, Cajkovac M, Jalenjack I. Liposomes with clindamycin hydrochloride in the therapy of acne vulgaris. Int J Pharm. 1992;85(1–3):97–101. doi:10.1016/0378-5173(92)90138-R
   Web of Science ®Google Scholar
• Masini V, Bonte F, Meybeck A, Wepierre J. Cutaneous bioavailability in hairless rats of tretinoin in liposome or gel. J Pharm Sci. 1993;82(1):17–21. doi:10.1002/jps.26008201048429486
   PubMed Web of Science ®Google Scholar
• Castro GA, Ferreira LA. Novel vesicular and particulate drug delivery systems for topical treatment of acne. Expert Opin Drug Deliv. 2008;5(6):665–679. doi:10.1517/17425247.5.6.66518532922
   PubMed Web of Science ®Google Scholar
• Shah SM, Ashtikar M, Jain AS, et al. LeciPlex, invasomes, and liposomes: a skin penetration study. Int J Pharm. 2015;490(1–2):391–403. doi:10.1016/j.ijpharm.2015.05.04226002568
   PubMed Web of Science ®Google Scholar
• Jung S, Otberg N, Thiede G, et al. Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol. 2006;126(8):1728–1732. doi:10.1038/sj.jid.570032316645589
   PubMed Web of Science ®Google Scholar
• Rahman SA, Abdelmalak NS, Badawi A, Elbayoumy T, Sabry N, El Ramly A. Tretinoin-based liposomal formulations: from lab to comparative clinical study in acne patients. Drug Deliv. 2016;23(4):1184–1193. doi:10.3109/10717544.2015.104157826004128
   PubMed Web of Science ®Google Scholar
• Eroğlu İ, Aslan M, Yaman Ü, et al. Liposome-based combination therapy for acne treatment. J Liposome Res. 2019;30(3):263–273. doi:10.1080/08982104.2019.163064631185768
   PubMed Web of Science ®Google Scholar
• Patel VB, Misra A, Marfatia YS. Clinical assessment of the combination therapy with liposomal gels of tretinoin and benzoyl peroxide in acne. AAPS PharmSciTech. 2001;2(3):1–5. doi:10.1208/pt0203_tn4
   Google Scholar
• Fluhr JW, Barsom O, Gehring W, Gloor M. Antibacterial effi cacy of benzoyl peroxide in phospholipid liposomes. A vehicle-controlled, comparative study in patients with papulopustular acne. Dermatology. 1999;198:273–277. doi:10.1159/00001812910393452
   PubMed Web of Science ®Google Scholar
• Musthaba SM, Baboota S, Ahmed S, Ahuja A, Ali J. Status of novel drug delivery technology for phytotherapeutics. Expert Opin Drug Deliv. 2009;6(6):625–637. doi:10.1517/1742524090298015419505192
   PubMed Web of Science ®Google Scholar
• Bilia AR, Guccione C, Isacchi B, Righeschi C, Firenzuoli F, Bergonzi MC. Essential oils: new perspectives in human health and wellness. Evid Based Complement Alternat Med. 2014;2014:1–14.
   Web of Science ®Google Scholar
• Daud FS, Pande G, Joshi M, Pathak R, Wankhede S. A study of antibacterial effect of some selected essential oils and medicinal herbs against acne causing bacteria. IJPSI. 2013;2(1):27–34.
   Google Scholar
• Valenti D, De Logu A, Loy G, et al. Liposome- incorporated santolina insularis essential oil: preparation, characterization, and in vitro antiviral activity. J Liposome Res. 2001;11(1):73–90. doi:10.1081/LPR-10010317119530920
   PubMed Web of Science ®Google Scholar
• Turina AV, Nolan MV, Zygadlo JA, Perillo MA. Natural terpenes: self-assembly and membrane partitioning. Biophys Chem. 2006;122:101–113. doi:10.1016/j.bpc.2006.02.00716563603
   PubMed Web of Science ®Google Scholar
• Biju SS, Ahuja A, Khar RK. Tea tree oil concentration in follicular casts after topical delivery: determination by high-performance thin layer chromatography using a perfused bovine udder model. J Pharma Sci. 2005;94(2):240–245. doi:10.1002/jps.20250
   PubMed Web of Science ®Google Scholar
• Sherry M, Charcosset C, Fessi H, Greige-Gerges H. Essential oils: encapsulated in liposomes: a review. J Liposome Res. 2013;23(4):268–275. doi:10.3109/08982104.2013.81988823879218
   PubMed Web of Science ®Google Scholar
• Kazi KM, Mandal AS, Biswas N, et al. A future of targeted drug delivery systems. J Adv Pharm Technol Res. 2010;1(4):374–380. doi:10.4103/0110-5558.7643522247876
   PubMedGoogle Scholar
• Abdelkader H, Alani AWG, Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv. 2014;2(2):87–100. doi:10.3109/10717544.2013.838077
   Google Scholar
• Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 2014;185:22–36. doi:10.1016/j.jconrel.2014.04.01524747765
   PubMed Web of Science ®Google Scholar
• Choi MJ, Maibach HI. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Phys. 2005;18(5):209–219. doi:10.1159/000086666
   PubMed Web of Science ®Google Scholar
• Manconi M, Sinico C, Valenti D, Lai F, Fadda AM. Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm. 2006;311(1–2):11–19. doi:10.1016/j.ijpharm.2005.11.04516439071
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1992;1104(1):226–232. doi:10.1016/0005-2736(92)90154-E1550849
   PubMed Web of Science ®Google Scholar
• Patel R, Prabhu P. Nanocarriers as versatile delivery systems for effective management of acne. Int J Pharm. 2020;579:119140. doi:10.1016/j.ijpharm.2020.11914032061843
   PubMed Web of Science ®Google Scholar
• Aggarwal G, Nagpal M, Kaur G. Development and comparison of nanosponge and niosome based gel for the topical delivery of terazotene. Pharm Nanotechnol. 2016;4(3):213–228. doi:10.2174/221173850466616080415421329052500
   PubMedGoogle Scholar
• Roberts MS, Mohammed Y, Pastore MN, et al. Topical and cutaneous delivery using nanosystems. J Control Release. 2017;247:86–105. doi:10.1016/j.jconrel.2016.12.02228024914
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen PL, Bouwstra JA. The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. J Control Release. 2003a;86(1):145–156. doi:10.1016/S0168-3659(02)00415-712490380
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen PL, Groenink HWW, de Graaff AM, Bouwstra JA. The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. J Control Release. 2003;90(2):243–255. doi:10.1016/S0168-3659(03)00202-512810306
   PubMed Web of Science ®Google Scholar
• Cristiano MC, Froiio F, Spaccapelo R, et al. Sulforaphane-loaded ultradeformable vesicles as a potential natural nanomedicine for the treatment of skin cancer diseases. Pharmaceutics. 2020;12(1):6. doi:10.3390/pharmaceutics12010006
   Web of Science ®Google Scholar
• Cosco D, Paolino D, Maiuolo J, et al. Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery. Int J Pharm. 2015;489(1–2):1–10. doi:10.1016/j.ijpharm.2015.04.05625899287
   PubMedGoogle Scholar
• Benson HAE. Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv. 2006;3(6):727–737. doi:10.1517/17425247.3.6.72717076595
   PubMedGoogle Scholar
• Bouwstra JA, De Graaff A, Groenink W, Honeywell L. Elastic vesicles: interaction with human skin and drug transport. Cell Mol Biol Lett. 2002;7(2):222–223.12097923
   PubMed Web of Science ®Google Scholar
• Jain A, Jain P, Umamaheshwari RB, Jain NK. Transfersomes—a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm. 2003;29(9):1013–1026. doi:10.1081/DDC-12002545814606665
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Tan RBH. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci. 2012;47(1):139–151. doi:10.1016/j.ejps.2012.05.01022664358
   PubMed Web of Science ®Google Scholar
• Jain S, Kale DP, Swami R, Katiyar SS. Codelivery of benzoyl peroxide & adapalene using modified liposomal gel for improved acne therapy. Nanomedicine. 2018;13(12):1481–1493. doi:10.2217/nnm-2018-000229972675
   PubMed Web of Science ®Google Scholar
• Ascenso A, Salgado A, Euletério C, et al. In vitro and in vivo topical delivery studies of tretinoin-loaded ultradeformable vesicles. Eur J Parm Biopharm. 2014;88(1):48–55. doi:10.1016/j.ejpb.2014.05.002
   PubMed Web of Science ®Google Scholar
• Hamblin MR, Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci. 2004;3(5):436–450. doi:10.1039/b311900a15122361
   PubMed Web of Science ®Google Scholar
• Park H, Lee J, Jeong S, et al. Lipase-sensitive transfersomes based on photosensitizer/polymerizable lipid conjugate for selective antimicrobial photodynamic therapy of acne. Adv Healthc Mater. 2016;5(24):3139–3147. doi:10.1002/adhm.20160081527863184
   PubMed Web of Science ®Google Scholar
• Rai S, Pandey V, Rai G. Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art. Nano Rev Exp. 2017;8(1):1325708. doi:10.1080/20022727.2017.132570830410704
   PubMed Web of Science ®Google Scholar
• Guo J, Ping Q, Sun G, Jiao C. Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int J Pharm. 2000;194(2):201–207. doi:10.1016/S0378-5173(99)00361-010692644
   PubMedGoogle Scholar
• Cevc G, Schätzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta. 2002;1564(1):21–30. doi:10.1016/S0005-2736(02)00401-712100992
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Williams AC, Barry BW. Can drug-bearing liposomes penetrate intact skin? J Pharm Pharmacol. 2006;58(4):415–429. doi:10.1211/jpp.58.4.000116597359
   PubMed Web of Science ®Google Scholar
• Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000;65(3):403–418. doi:10.1016/S0168-3659(99)00222-910699298
   PubMed Web of Science ®Google Scholar
• Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release. 2005;106(1–2):99–110. doi:10.1016/j.jconrel.2005.04.00715935505
   PubMed Web of Science ®Google Scholar
• Marto J, Vitor C, Guerreiro A, et al. Ethosomes for enhanced skin delivery of griseofulvin. Colloids Surf B. 2016;146:616–623. doi:10.1016/j.colsurfb.2016.07.021
   PubMed Web of Science ®Google Scholar
• Apriani EF, Rosana Y, Iskandarsyah I. Formulation, characterization, and in vitro testing of azelaic acid ethosome-based cream against propionibacterium acnes for the treatment of acne. J Adv Pharm Technol Res. 2019;10(2):75–80. doi:10.4103/japtr.JAPTR_289_1831041186
   PubMed Web of Science ®Google Scholar
• Babaie S, Del Bakhshayesh AR, Ha JW, Hamishehkar H, Kim KH. Invasome: a novel nanocarrier for transdermal drug delivery. Nanomaterials. 2020;10(2):341. doi:10.3390/nano10020341
   Web of Science ®Google Scholar
• El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM. Dapsone-loaded invasomes as a potential treatment of acne: preparation, characterization, and in vivo skin deposition assay. AAPS PharmSciTech. 2018;19(5):2174–2184. doi:10.1208/s12249-018-1025-029725903
   PubMed Web of Science ®Google Scholar